SCHEMBL6829078

SCHEMBL6829078

CC(=O)N1CCC(C(=O)Nc2c(C)cc3c(c2C)c2ccccc2n3C(C)C)CC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 6/20 0.63
ROCK2 O75116 1/20 0.43
ROCK1 Q13464 1/20 0.43
MAPK8 P45983 1/20 0.41
MAPK10 P53779 1/20 0.41
TP53 P04637 3/20 0.40
ALOX15 P16050 1/20 0.40
MAPK1 P28482 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MAPT P10636 2/20 0.40
LMNA P02545 1/20 0.39
KMT2A Q03164 2/20 0.39
HDAC3 O15379 2/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC2 Q92769 2/20 0.39
REV1 Q9UBZ9 2/20 0.38
MEN1 O00255 1/20 0.38
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6826862 0.94 NPY5R (0.61) NPY5RROCK2ROCK1MAPK8MAPK10
SCHEMBL6823457 0.91 NPY5R (0.62) NPY5RTP53HSD17B10MAPTLMNA
SCHEMBL6823387 0.91 NPY5R (0.61) NPY5RTP53HSD17B10MAPTLMNA
SCHEMBL6829077 0.87 NPY5R (0.61) NPY5RTP53MAPTLMNAPOLB
SCHEMBL6824384 0.87 NPY5R (0.59) NPY5RTP53MAPTLMNA
SCHEMBL6823480 0.86 NPY5R (0.56) NPY5RMAPK8KMT2AEPHX2
SCHEMBL6828992 0.83 NPY5R (0.67) NPY5RMAPK8MAPK10MAPTHDAC3
SCHEMBL6829275 0.83 NPY5R (0.69) NPY5RTP53MAPTKMT2AREV1
SCHEMBL6826590 0.82 NPY5R (0.60) NPY5RHSD17B10MAPTKMT2APOLB
SCHEMBL6826986 0.81 NPY5R (0.67) NPY5RMAPTREV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040067999-A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands ASTRAZENECA AB (SE) 2004-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040067999-A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands NPY5R, NPY1R, NPY2R NPY5R 1/4885ROCK2 791/4885ROCK1 382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.